In B-cell lymphoma, TOX is overexpressed in precursor B lymphoblastic lymphoma (B-LBL), diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL), and a small proportion of Burkitt lymphoma (BL) patients. This evidence concerns the gene TOX and B-cell non-Hodgkin lymphoma.